EU MDR Clinical Research Organisation

Where device
manufacturers
build regulatory
certainty.

Premier European CRO specialising in EU MDR regulatory affairs, PMCF clinical investigations, clinical data management and digital clinical studies.

PMCF Active
50+
Device programs delivered under EU MDR since 2020.
0
Major non-conformities in Notified Body submissions.
19yr
Average senior team device expertise.
· London · Paris · Dublin · Tokyo
ISO 13485 Certified QMS
clientcare@eclevar.com
EUCROF / xShare - Amsterdam - 2 February 2026

Eclevar Medtech wins
Platinum Award
for Clinical Research Excellence

Eclevar Medtech was awarded the Platinum Award at the xShare Open Call for Clinical Research, organised by EUCROF (European CRO Federation) and co-funded by the European Union. Recognised as the top-ranked CRO in Europe for innovation in clinical validation, data interoperability, and patient-centred study design.

Platinum Award Rank 1
EUCROF European CRO Federation
Amsterdam - 2 February 2026
EU Co-Funded

Co-funded by the European Union xShare EHR Xchange Format - Open Call for Clinical Research - Best CRO Innovation in EU.

Clinical Research Team Award
xShare Clinical Excellence 2026 EUCROF - CO-FUNDED BY THE EUROPEAN UNION
Eclevar Medtech Platinum Award 2026
Capabilities & Focus

End-to-end clinical execution
for complex devices.

We combine comprehensive clinical study and data management services with deep regulatory know-how and digital capabilities. Our focus is on several highly demanding therapeutic verticals.

Therapeutic Focus

Cardiovascular

Expertise in the most technically demanding Class III categories, including TAVI and other structural heart devices, guidewires and perivascular devices.

VARC-3Structural HeartLAAO
Therapeutic Focus

Orthopedics & Spine

PMCF biometric architecture for joint reconstruction and spinal implants. Seamless implant registry integration (NJR, EPRD) and strict radiographic standardisation.

NJR / EPRDRadiographic CharterClass III Implants
Therapeutic Focus

Neuromodulation

Annex IX/X clinical strategies for Class III active implants: SCS, DBS, and peripheral nerve devices. Built to manage complex 10-year follow-up requirements.

SCS & DBSAnnex IX / XLong-Term Follow-Up
Therapeutic Focus

Advanced Wound Care

Strategic PMCF programs and wound management for NPWT, bioengineered tissue, and antimicrobial dressings. Powered by EWMA collaboration and REDIT registry access.

NPWTTissue EngineeringEWMA Registries
Core Service

Clinical Operations & PMCF

End-to-end execution from pre-market FIH studies to full PMCF registry studies. We manage ISO 14155:2020 protocol design, Ethics Committee approvals, and conduct rigorous site monitoring.

ISO 14155:2020PMCF ExecutionIIS Programs
Core Service

Data Management & Regulatory

21 CFR Part 11 compliant data capture via our proprietary MILO EDC platform. Combined with expert biostatistics, systematic CER authoring, and Notified Body-ready clinical evaluation.

MILO EDCCER AuthoringBiostatistics
Executive Leadership

Experts from Both Sides of the Table

Mark DaCosta
CMO & Head of Cardiovascular

Prof. Mark DaCosta

Direct experience in high-level Notified Body Q&A cycles for Class III medical devices.

Class IIIRegulatory OpsCardiac Surgeon
Nikhil Khadabadi
CMO & Head of Orthopedics & Spine

Dr. Nikhil Khadabadi

Former TÜV SÜD Senior Reviewer with Class III devices focus. Specialises in implantable device clinical evidence processes.

Ex-TÜV SÜDClass IIIOrthopedic Surgeon
Yumiko Kida
CMO & Head of Dental

Dr. Yumiko Kida

Former Notified Body Assessor (Intertek and SGS) with over two decades of dual-perspective expertise.

Ex-NB AssessorDental Devices
Nancy Boodhun
Head of Clinical Operations

Nancy Boodhun

Senior lead for site qualification and ISO 14155:2020 compliance oversight.

Clinical OpsISO 14155
Sebastien Meier
Chief Data Officer

Sébastien Meier

30 years in Biometrics. Architect of the MILO EDC platform and data governance.

BiostatisticsEDC
Proprietary Technology

MILO EDC: The inspection-
native data platform.

Generic clinical study platforms are not built for medical devices. When fields lack Annex XIV mapping or audit trails fail on field modifications, you fail Notified Body review.

MILO was built to make these gaps structurally impossible. Inspection readiness is not a pre-audit sprint — it is the default state encoded into every record.

AI eCRF Generator

Reads your PMCF Protocol and proposes a complete EDC dictionary with Annex XIV mapping pre-populated.

Smart Query Engine

AI-assisted cross-visit anomaly detection. Reduces manual data review by 60%.

Inspection Dashboard

Real-time TMF completeness scoring. Know your Notified Body inspection readiness score instantly.

Part 11 Native

Immutable audit trail from Day 1. No configuration required. Notified Body compliant out of the box.

MILO EDC Platform
Medical Intelligence
for Lifecycle Outcomes
The only EDC built specifically for EU MDR.
MILO EDC Dashboard Illustration
21
CFR Part 11
AI
eCRF Build
0
Config Required
Track Record & Execution

Evidence you can
build a strategy on.

A structured engagement model that moves fast without cutting regulatory corners. From signed agreement to Notified Body submission.

50+
EU MDR device programs delivered since 2022.
0
Major Notified Body non-conformities across submissions.
4
Specialised therapeutic verticals.
8
Countries with direct in-house CRA coverage.
1

Clinical Strategy

Assess PMCF obligations, Annex XIV gaps, and define the fastest compliant pathway.

2

Protocol & DMP

Endpoint-to-CER mapping and Data Management Plan authored prior to EDC build.

3

Ethics & Submissions

Full EC dossier preparation and national CA submission. EUDAMED registration.

4

EDC & Activation

MILO EDC validated, sites qualified, investigators trained, and monitoring activated.

5

PMCF Delivery

Database lock, statistical analysis, and final report ready for Notified Body review.

Our Global
Infrastructure

Direct operational presence and strategic corridors across major medical device markets worldwide.

Ireland
Global Headquarters
United Kingdom
Strategic Corridor
United States
Strategic Corridor
LATAM
Strategic Corridor
India
Strategic Corridor
Tokyo, Japan
Strategic Corridor
Germany
In-House CRA
France
In-House CRA
Spain
In-House CRA
Italy
In-House CRA
Nordics
Partnership
Global Headquarters
In-House CRA
Partnership
Strategic Corridor
Reach out to our team members. Guaranteed Response Within 24 Hours.

Your pending Notified Body submission
should be the last one
with findings.

Whether you are designing a first PMCF program, remediating a legacy EDC before re-certification, preparing for an inspection, or building IIS evidence for indication expansion, the Eclevar Medtech team delivers clinical strategy built for regulatory success.

Paris, France
58 Rue de Monceau, 75008
London, UK
124-128 City Road, EC1V 2NX
Tokyo, Japan
PMDA Corridor

Reforming Clinical Evaluation of Medical Devices in Europe